Sbir topic 376: a noninvasive pet imaging strategy for longitudinal monitoring of immune contexture in the tumor microenvironment. Moonshot.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91018C00024
- Awardee
-
Cellsight Technologies, Inc. UEI E3UQXACGFR43
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,641
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Pre-Solicitation · PHS20181 · Posted Jun 29, 2017
- Contract value 100% obligated
- $299,640.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 9 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Francisco, CA 94107, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$0 | |
| Original award | $299,641 |
About this award
This is a $299,640.99 Firm Fixed Price contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Cellsight Technologies, Inc. The contract is for research and development services related to a noninvasive PET imaging strategy for longitudinal monitoring of the tumor microenvironment, under the Small Business Innovation Research (SBIR) program. The contract was set aside for small business participation. Cellsight Technologies, Inc. is a molecular imaging company that specializes in developing PET imaging companion diagnostics for cancer immunotherapy. Through this and previous SBIR contracts, the company is advancing the development of its [18F]F-ARAG imaging agent to assess response to immunotherapy and monitor cardiotoxicity associated with cancer treatments.
Quick answers
Who was awarded contract 75N91018C00024?
75N91018C00024 was awarded to Cellsight Technologies, Inc. by National Cancer Institute (National Institutes of Health) on September 17, 2018.
How much is contract 75N91018C00024 worth?
The government has obligated $299,641 on 75N91018C00024.
Was contract 75N91018C00024 competed?
The extent of competition for 75N91018C00024 was full and open competition after exclusion of sources. The government received 9 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award